However, its chronic inhibition may lead to increased body weight (obesity); therefore, strategies to maintain the body weight are critical to sustaining the metabolic benefit of GSK-3β inhibition. Here, GSK3B is linked to obesity due to melanocortin 4 receptor deficiency.